Research Ethics in Reproductive Medicine

Research Ethics in Reproductive Medicine

Research Ethics in Reproductive Medicine

On this page

Core Principles & Guidelines - Ethical Pillars

  • Ethical Pillars:
    • Beneficence: Act in participant's best interest.
    • Non-maleficence: Do no harm.
    • Autonomy: Respect participant's informed choices.
    • Justice: Ensure fair distribution of research benefits/burdens.
  • ICMR Guidelines (2017): Comprehensive framework for all Indian biomedical research, including reproductive medicine.
    • Mandates: Informed consent, confidentiality, privacy.
    • Specific guidance: ART, human genetics, embryo research.
  • IEC Approval: Mandatory prior to any research.
  • Vulnerable Populations: Enhanced safeguards for women, gamete donors, embryos.

⭐ ICMR guidelines strictly regulate research on pre-implantation embryos and prohibit commercialization of human reproduction. oka

  • Key Challenges:
    • Vulnerability (e.g., infertile patients, gamete donors).
    • Complexity of procedures & long-term implications (e.g., genetic data, embryo fate).
    • Potential for coercion or undue influence.
    • Therapeutic misconception (research vs. treatment confusion).
    • Need for specific, ongoing (dynamic) consent for stored gametes/embryos.

⭐ In ART research, explicit consent for disposition of unused embryos (cryopreservation, donation, research, or discard) is mandatory and ethically paramount.

Vulnerable Groups Protection - Shielding Subjects

  • Key Vulnerable Groups:
    • Pregnant women, fetuses, neonates (unique physiological/ethical status)
    • Embryos (ART-derived, research implications)
    • Children & adolescents (reproductive health decisions)
    • Infertile individuals/couples (potential for exploitation)
    • Gamete donors/recipients, surrogates (third-party reproduction complexities)
  • Core Ethical Safeguards:
    • Autonomy: Strict, clear informed consent/assent.
    • Beneficence/Non-maleficence: Minimal risk or direct, significant benefit; fetal protection paramount.
    • Justice: Fair selection, prevent exploitation. Equitable burden/benefit sharing.
    • Oversight: Rigorous IEC/IRB review; Data Safety Monitoring Boards (DSMBs) often vital.
    • Voluntariness: No coercion or undue inducement for participation. Ethical considerations in reproductive research

⭐ ICMR guidelines: Research on pregnant women/fetuses only if direct therapeutic benefit to them, or minimal risk & knowledge is vital and unobtainable otherwise.

Emerging Tech Ethics - Frontier Dilemmas

  • Genetic Interventions:
    • Somatic vs. Germline gene editing (e.g., CRISPR-Cas9): Ethical concerns regarding heritability, off-target effects, enhancement vs. therapy.
    • Preimplantation Genetic Testing (PGT): Selection for/against traits, designer babies, disability rights.
  • ART Innovations:
    • Uterine transplantation: Beneficence vs. non-maleficence for donor and recipient, fetal risks.
    • In vitro gametogenesis (IVG): Creation of gametes from somatic cells; implications for parenthood, kinship.
    • Artificial wombs (Ectogenesis): Potential benefits for extreme prematurity vs. impact on maternal-fetal bonding, societal views on pregnancy.
  • Gamete/Embryo Research:
    • Embryo cryopreservation: Status of stored embryos, disposition decisions.
    • Research on surplus IVF embryos: Moral status of the embryo, limits of research (e.g., 14-day rule).
    • Mitochondrial Replacement Therapy (MRT): "Three-parent babies", identity, lineage.

Somatic vs. Germline Gene Editing

⭐ The 14-day rule for embryo research, prohibiting cultivation of human embryos in vitro beyond 14 days post-fertilization or the appearance of the primitive streak, is a significant international ethical guideline, though subject to ongoing debate with scientific advancements (e.g., blastoid models).

High‑Yield Points - ⚡ Biggest Takeaways

  • Informed consent is paramount, detailing risks/benefits, especially for vulnerable groups.
  • Strict confidentiality of genetic and personal data is essential.
  • Balance beneficence and non-maleficence, particularly in embryo and gamete research.
  • Justice demands fair subject selection and equitable distribution of outcomes.
  • Mandatory adherence to ICMR guidelines for reproductive research in India.
  • Heightened ethical review for ART, genetic studies, and surrogacy research.

Practice Questions: Research Ethics in Reproductive Medicine

Test your understanding with these related questions

For medical termination of pregnancy, consent is given by-

1 of 5

Flashcards: Research Ethics in Reproductive Medicine

1/10

In case of Incomplete abortion the most appropriate management is to do _____

TAP TO REVEAL ANSWER

In case of Incomplete abortion the most appropriate management is to do _____

dilatation and curettage

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial